Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions |
Mar. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Allowance for credit losses | $ 89 | $ 91 |
| Accumulated depreciation | 1,005 | 958 |
| Current portion of debt, fair value | $ 242 | $ 282 |
| Series A common stock | ||
| Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
| Common stock, shares authorized (in shares) | 4,000,000,000 | 4,000,000,000 |
| Common stock, shares issued (in shares) | 394,321,833 | 389,654,508 |
| Common stock, shares outstanding (in shares) | 394,321,833 | 389,654,508 |
| Series B common stock | ||
| Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
| Common stock, shares authorized (in shares) | 150,000,000 | 150,000,000 |
| Common stock, shares issued (in shares) | 9,114,716 | 8,927,840 |
| Common stock, shares outstanding (in shares) | 9,114,716 | 8,927,840 |
| Series C common stock | ||
| Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
| Common stock, shares authorized (in shares) | 4,000,000,000 | 4,000,000,000 |
| Common stock, shares issued (in shares) | 0 | 0 |